{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04828",
    "Peptide Name": "ParalichenysinDY4 (natural AMPs; bacteriocins; Gram-positive bacteria, prokaryotes; UCLL1)",
    "Source": "Bacillus paralicheniformisDY4;  human microbiota:gut",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "MSGIIRVTPAELRQMADRYQKESGDVTEQVNQRLDQMINQLQDMWEGESSRAFSEQYQELRPSFIKMAELLSDVSKQLHQTANTLESTDQDIASQIRG",
    "Sequence Length": 98,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Anti-MRSA"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Unknown",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": -5,
    "Boman Index": 2.72,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "33%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is similar (29.69%) toScygonadin2Q: 13%. GRAVY: -0.796; mol Wt: 11277.571; mol formula: C478H775N138O164S5; mol ex coeff: 8530. This is a unique peptide sequence.Activity: active against Gram+ C. perfringens ATCC 13124 and 8 other strains (MIC 4-8 ug/ml), L. monocytogenes ATCC 19111 (MIC 32 ug/ml), S. aureus ATCC 43300 or  ATCC 29213 (MIC 32-64 ug/ml), S. agalactiae ATCC 13813 (MIC 2 ug/ml), S. suis 0859 (MIC 2 ug/ml), E. faecalis 012-2 (MIC 16 ug/ml), but not Gram- S.Typhimurium ATCC 14028 (MIC > 256 ug/ml), E.coli DH5alpha or K88 or EHEC O157:H7 (MIC >256 ug/ml), A.pleuropneumoniae APP 18 (MIC>256 ug/ml), and  P.aeruginosa ATCC 27853 (MIC>256 ug/ml).Antimicrobial robustness: >90% activity retained after treatment at 80-100oC. pH-insensitive (pH 2-11); insensitive to treatment of pepsin, trypsin, but sensitive to proteinase K.MOA:bacteria:C. perfringens:  permeated membranes.Animal model:mouse: peptide treatment at 50 and 100 mg/kg reduced CFU in mouse small intestine, cecum, and colon 24 h post-infection (orally/orally). More models tested (TBA).",
    "Author": "Wang H, Wang L, Zhang F, Li X, Wang S, Gao D, Li X, Qian P.2024",
    "Reference": "Int J Biol Macromol. 2024 Sep 6;279(Pt 4):135412. doi: 10.1016/j.ijbiomac.2024.135412.PubMed",
    "Title": "ParalichenysinDY4, a novel bacteriocin-like substance, is employed to control Clostridium perfringens."
  },
  "3D Structure": []
}